Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 72.76 -1.11%   SPY: 163.45 -1.38%
Quote Spy CRIS NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Curis (CRIS)

@ 4:00 PM
Click the portfolio to add CRIS:
Close [X]
+ Add CRIS to Portfolio
  
  Last Trade: $3.39 -0.04 (-1.17%)
  Volume: 223,221 39% of avg daily volume
       
  Avg Volume: 573,126
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 3.36 - 3.42
  Open: 3.42
  Previous Close: 3.43
  52-wk Range: 2.66 - 5.51
  Market Cap: 274.9M
  P/E: -11.4
  Div Yield: $0.00 (0.00%)
Indexes
Biotechnology Stocks (-1.7%)
Spy CRIS

? Pro holders
? Member holders
? Items submitted
Additional CRIS resources



Customize Links
To see which Pros and tickerspy members own CRIS Sign up now
Latest CRIS Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Curis to Present at the 2013 Wells Fargo Securities Healthcare Conference
CRIS  
Linked by GlobeNewswire - June 11, 07:13AM from (globenewswire.com)
LEXINGTON, Mass., June 11, 2013 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused company seeking to develop  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Curis Announces CUDC-427 (GDC-0917) Phase I Clinical Data Presented at ASCO 2013 Annual Meeting
CRIS  
Linked by GlobeNewswire - June 03, 07:13AM from (globenewswire.com)
LEXINGTON, Mass., June 3, 2013 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused company seeking to develop  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Curis Announces Appointment of Mani Mohindru, Ph.D., as Vice President of Corporate Strategy and Investor Relations
CRIS  
Linked by GlobeNewswire - May 31, 07:13AM from (globenewswire.com)
LEXINGTON, Mass., May 31, 2013 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused company seeking to develop  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Curis to Present at the Jefferies 2013 Global Healthcare Conference
CRIS  
Linked by GlobeNewswire - May 30, 08:43AM from (globenewswire.com)
LEXINGTON, Mass., May 30, 2013 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused company seeking to develop  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Curis to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference
CRIS  
Linked by GlobeNewswire - May 22, 07:13AM from (globenewswire.com)
LEXINGTON, Mass., May 22, 2013 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused company seeking to develop  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Curis Announces Approval of Erivedge(R) in Australia
CRIS  
Linked by GlobeNewswire - May 10, 07:13AM from (globenewswire.com)
LEXINGTON, Mass., May 10, 2013 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused company seeking to develop  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Curis Reports First Quarter 2013 Financial Results
CRIS  
Linked by GlobeNewswire - April 30, 07:13AM from (globenewswire.com)
LEXINGTON, Mass., April 30, 2013 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused company seeking to develop  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Curis to Release First Quarter 2013 Financial Results and Hold Conference Call on April 30, 2013
CRIS  
Linked by GlobeNewswire - April 23, 07:13AM from (globenewswire.com)
LEXINGTON, Mass., April 23, 2013 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a drug development company seeking to develop  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Curis to Present at the BioCentury Future Leaders in the Biotech Industry Conference
CRIS  
Linked by GlobeNewswire - March 29, 07:13AM from (globenewswire.com)
LEXINGTON, Mass., March 29, 2013 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused company seeking to develop  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Curis to Present at the Roth Capital Partners 25th Annual Growth Stock Conference
CRIS  
Linked by GlobeNewswire - March 11, 07:13AM from (globenewswire.com)
LEXINGTON, Mass., March 11, 2013 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused company seeking to develop  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 11



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource